Adenosine Receptor Agonist [EPC]

Adenosine Receptor Agonist [EPC] was reported 7385 times

Drugs of the Adenosine Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CORONARY STEAL SYNDROME 9 0.6000
1 CARDIAC PERFUSION DEFECT 7 0.1321
2 BENIGN SOFT TISSUE NEOPLASM 5 0.1316
3 RADIOISOTOPE UPTAKE INCREASED 4 0.0909
4 RADIATION OVERDOSE 4 0.0741
5 TACHYCARDIA INDUCED CARDIOMYOPATHY 7 0.0654
6 COMPLEMENT FACTOR C4 INCREASED 3 0.0526
7 ALCOHOL USE DISORDER 8 0.0468
8 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 3 0.0462
9 HEMIPLEGIC MIGRAINE 14 0.0413
10 SKIN SQUAMOUS CELL CARCINOMA RECURRENT 4 0.0351
11 BLOOD CHOLINESTERASE INCREASED 3 0.0349
12 INTRACARDIAC MASS 6 0.0339
13 SCAN MYOCARDIAL PERFUSION ABNORMAL 5 0.0325
14 SINUS ARREST 49 0.0312
15 INJECTION SITE EXTRAVASATION 361 0.0292
16 PERICHONDRITIS 3 0.0291
17 CARDIAC ARREST NEONATAL 4 0.0290
18 VENTRICULAR ASYSTOLE 5 0.0287
19 PARANASAL SINUS HAEMORRHAGE 3 0.0270
20 SCROTAL DISORDER 7 0.0232
21 PITUITARY APOPLEXY 4 0.0227
22 THERAPEUTIC PRODUCT EFFECT PROLONGED 10 0.0221
23 NODAL RHYTHM 28 0.0191
24 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 42 0.0191
25 VAGINAL FLATULENCE 5 0.0165
26 ATRIOVENTRICULAR BLOCK SECOND DEGREE 46 0.0151
27 CARDIAC NEOPLASM UNSPECIFIED 3 0.0150
28 ATRIOVENTRICULAR BLOCK 111 0.0143
29 ATRIOVENTRICULAR BLOCK COMPLETE 93 0.0139
30 ELECTROCARDIOGRAM CHANGE 13 0.0137
31 SEIZURE LIKE PHENOMENA 23 0.0135
32 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 11 0.0135
33 SUPRAVENTRICULAR TACHYCARDIA 124 0.0129
34 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 4 0.0125
35 ARTERIAL THERAPEUTIC PROCEDURE 3 0.0122
36 EXTRAVASATION 50 0.0122
37 LOW CARDIAC OUTPUT SYNDROME 4 0.0120
38 MYOCARDIAL DEPRESSION 3 0.0116
39 FALSE NEGATIVE INVESTIGATION RESULT 8 0.0114
40 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 37 0.0112
41 ARTERIOSPASM CORONARY 42 0.0105
42 EAR INFLAMMATION 3 0.0104
43 GENITAL PARAESTHESIA 3 0.0103
44 PULMONARY VALVE STENOSIS 8 0.0100
45 INFUSION SITE EXTRAVASATION 60 0.0096
46 PSYCHOGENIC SEIZURE 8 0.0086
47 CARDIAC PROCEDURE COMPLICATION 5 0.0082
48 NEONATAL HYPOTENSION 3 0.0082
49 GENERALISED BULLOUS FIXED DRUG ERUPTION 3 0.0081
50 ADMINISTRATION SITE EXTRAVASATION 8 0.0080
51 BUNDLE BRANCH BLOCK LEFT 29 0.0068
52 CARDIAC OUTPUT DECREASED 6 0.0068
53 UNRESPONSIVE TO STIMULI 171 0.0066
54 VEIN RUPTURE 11 0.0066
55 IMMEDIATE POST-INJECTION REACTION 7 0.0064
56 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
57 SUPRAVENTRICULAR EXTRASYSTOLES 20 0.0059
58 METASTATIC SQUAMOUS CELL CARCINOMA 3 0.0059
59 PEMPHIGOID 44 0.0058
60 PULSE ABSENT 27 0.0057
61 MULTIPLE CONGENITAL ABNORMALITIES 8 0.0056
62 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
63 FIBROMA 5 0.0054
64 PRODUCT APPEARANCE CONFUSION 5 0.0054
65 VENTRICULAR FIBRILLATION 59 0.0053
66 BRONCHOSPASM 75 0.0053
67 CONTRAST MEDIA REACTION 12 0.0051
68 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22 0.0051
69 PHYSICAL PRODUCT LABEL ISSUE 6 0.0050
70 MEAN PLATELET VOLUME INCREASED 3 0.0050
71 BRADYCARDIA 261 0.0049
72 SINUS NODE DYSFUNCTION 9 0.0049
73 MONOCYTOSIS 3 0.0048
74 HYPOPERFUSION 5 0.0048
75 DILATATION VENTRICULAR 10 0.0048
76 NODAL ARRHYTHMIA 4 0.0046
77 ARRHYTHMIA SUPRAVENTRICULAR 5 0.0046
78 ANISOCYTOSIS 3 0.0046
79 BLOOD PRESSURE IMMEASURABLE 7 0.0046
80 VENTRICULAR TACHYCARDIA 74 0.0045
81 CARDIAC ARREST 367 0.0044
82 VENTRICULAR EXTRASYSTOLES 46 0.0044
83 ELECTROCARDIOGRAM ST-T CHANGE 3 0.0042
84 EXFOLIATIVE RASH 11 0.0042
85 SINUS BRADYCARDIA 40 0.0041
86 GASTRIC MUCOSAL LESION 3 0.0041
87 PRODUCT PACKAGING CONFUSION 10 0.0041
88 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
89 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
90 LEFT ATRIAL DILATATION 5 0.0039
91 POSTICTAL STATE 4 0.0038
92 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
93 DEVICE CONNECTION ISSUE 8 0.0038
94 INAPPROPRIATE AFFECT 6 0.0038
95 INCORRECT PRODUCT ADMINISTRATION DURATION 82 0.0038
96 ELECTROMECHANICAL DISSOCIATION 3 0.0038
97 TACHYARRHYTHMIA 9 0.0036
98 KOUNIS SYNDROME 8 0.0035
99 THYROTOXIC CRISIS 4 0.0035
100 MOANING 4 0.0035
101 SICK SINUS SYNDROME 4 0.0035
102 ALCOHOL WITHDRAWAL SYNDROME 3 0.0034
103 DILATATION ATRIAL 4 0.0034
104 BLOOD PRESSURE DECREASED 226 0.0034
105 SUPERINFECTION 5 0.0033
106 PEPTIC ULCER 11 0.0033
107 BLOOD PRESSURE SYSTOLIC DECREASED 15 0.0033
108 ESSENTIAL HYPERTENSION 6 0.0033
109 CONDUCTION DISORDER 6 0.0033
110 ABULIA 3 0.0032
111 PRESYNCOPE 77 0.0032
112 HEART RATE DECREASED 110 0.0031
113 SINUS ARRHYTHMIA 4 0.0031
114 BRADYARRHYTHMIA 5 0.0030
115 INJECTION RELATED REACTION 5 0.0030
116 VENTRICULAR ARRHYTHMIA 11 0.0030
117 CORONARY ARTERY THROMBOSIS 6 0.0030
118 STENOTROPHOMONAS INFECTION 4 0.0029
119 FEMALE GENITAL TRACT FISTULA 5 0.0029
120 INJECTION SITE OEDEMA 5 0.0029
121 BRUGADA SYNDROME 3 0.0029
122 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
123 VOMITING PROJECTILE 8 0.0028
124 ATRIAL FLUTTER 22 0.0028
125 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 14 0.0027
126 CONTRAST MEDIA ALLERGY 5 0.0027
127 GASTRIC ULCER HAEMORRHAGE 15 0.0027
128 MYOSITIS 24 0.0027
129 LIGAMENT INJURY 3 0.0026
130 ORAL MUCOSAL ERYTHEMA 4 0.0026
131 CONVERSION DISORDER 5 0.0026
132 MUSCLE CONTRACTIONS INVOLUNTARY 9 0.0026
133 GRANULOMATOSIS WITH POLYANGIITIS 3 0.0025
134 CARDIOGENIC SHOCK 35 0.0024
135 ATRIAL TACHYCARDIA 5 0.0024
136 POST PROCEDURAL HAEMATOMA 4 0.0024
137 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 14 0.0024
138 VENTRICULAR DYSFUNCTION 6 0.0023
139 SEIZURE 267 0.0023
140 MYOCARDIAL ISCHAEMIA 26 0.0023
141 RADICULOPATHY 6 0.0023
142 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
143 CHOLESTATIC LIVER INJURY 5 0.0022
144 HAEMODYNAMIC INSTABILITY 17 0.0022
145 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
146 APNOEA 17 0.0022
147 ISCHAEMIA 10 0.0022
148 CARDIOVERSION 3 0.0021
149 INJECTION SITE HYPOAESTHESIA 3 0.0021
150 INFUSION SITE PAIN 27 0.0021
151 LONG QT SYNDROME 5 0.0021
152 DIABETES INSIPIDUS 5 0.0021
153 HYPOTENSION 409 0.0020
154 HYPERTHERMIA MALIGNANT 3 0.0020
155 HYPERPARATHYROIDISM SECONDARY 5 0.0020
156 CORONARY ARTERY STENOSIS 10 0.0020
157 HEART RATE ABNORMAL 11 0.0020
158 ACUTE MYOCARDIAL INFARCTION 58 0.0020
159 RESPIRATORY ARREST 54 0.0020
160 PROCEDURAL COMPLICATION 15 0.0020
161 INCORRECT DRUG ADMINISTRATION DURATION 55 0.0020
162 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
163 STRESS CARDIOMYOPATHY 11 0.0019
164 CHRONIC SINUSITIS 7 0.0019
165 GASTROINTESTINAL INJURY 5 0.0019
166 SENSATION OF HEAVINESS 7 0.0018
167 MEDICAL PROCEDURE 3 0.0018
168 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
169 PROCTITIS 5 0.0018
170 FEAR OF DEATH 4 0.0018
171 BLOOD LOSS ANAEMIA 4 0.0018
172 PNEUMONIA ASPIRATION 44 0.0018
173 BLOOD PH DECREASED 3 0.0018
174 EYE MOVEMENT DISORDER 12 0.0018
175 FANCONI SYNDROME ACQUIRED 3 0.0017
176 LOSS OF CONSCIOUSNESS 218 0.0017
177 STRIDOR 5 0.0017
178 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
179 RETCHING 35 0.0016
180 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
181 RETINAL TEAR 4 0.0016
182 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
183 INCONTINENCE 17 0.0016
184 HYPERAMMONAEMIA 8 0.0016
185 NON-CARDIAC CHEST PAIN 5 0.0016
186 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
187 VENTRICULAR HYPOKINESIA 5 0.0016
188 ANAL INCONTINENCE 14 0.0016
189 HEART RATE INCREASED 154 0.0016
190 PRODUCT LABEL CONFUSION 9 0.0015
191 CARDIO-RESPIRATORY ARREST 63 0.0015
192 LIBIDO INCREASED 3 0.0015
193 CIRCULATORY COLLAPSE 25 0.0015
194 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
195 LIVEDO RETICULARIS 3 0.0014
196 CHEST PAIN 265 0.0014
197 THERAPEUTIC RESPONSE DELAYED 4 0.0014
198 SYRINGE ISSUE 25 0.0014
199 ENDOTRACHEAL INTUBATION 4 0.0014
200 EAR SWELLING 3 0.0014
201 FOETAL DISTRESS SYNDROME 3 0.0014
202 AORTIC VALVE INCOMPETENCE 6 0.0014
203 PALLOR 38 0.0014
204 ATRIAL FIBRILLATION 135 0.0014
205 SYNCOPE 137 0.0014
206 APHASIA 41 0.0014
207 CARDIAC PACEMAKER INSERTION 8 0.0013
208 SINUS TACHYCARDIA 19 0.0013
209 MITRAL VALVE INCOMPETENCE 15 0.0013
210 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
211 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
212 ECONOMIC PROBLEM 20 0.0013
213 TROPONIN INCREASED 10 0.0013
214 DIASTOLIC DYSFUNCTION 4 0.0013
215 NEPHROGENIC ANAEMIA 6 0.0013
216 BRAIN DEATH 4 0.0013
217 ROSACEA 6 0.0013
218 CARDIOPULMONARY FAILURE 5 0.0013
219 RESPIRATORY RATE DECREASED 4 0.0013
220 INFUSION SITE SWELLING 8 0.0013
221 RESPIRATORY DISTRESS 35 0.0013
222 TREMOR 210 0.0013
223 MENTAL STATUS CHANGES 35 0.0013
224 CHEST DISCOMFORT 129 0.0013
225 TRICUSPID VALVE INCOMPETENCE 10 0.0013
226 HEPATIC CYTOLYSIS 16 0.0013
227 LACUNAR INFARCTION 3 0.0013
228 ACUTE PULMONARY OEDEMA 7 0.0012
229 SKIN EROSION 4 0.0012
230 HEMIPARESIS 21 0.0012
231 INCOHERENT 8 0.0012
232 POSTURE ABNORMAL 4 0.0012
233 RESPIRATORY DEPRESSION 15 0.0012
234 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
235 ANHEDONIA 32 0.0012
236 DEVICE INFUSION ISSUE 3 0.0012
237 TACHYCARDIA 107 0.0012
238 PROTEIN URINE PRESENT 6 0.0012
239 CATHETER SITE HAEMORRHAGE 3 0.0012
240 FACIAL PARALYSIS 10 0.0012
241 PHLEBITIS 6 0.0012
242 HYPERLIPIDAEMIA 14 0.0012
243 FLUID OVERLOAD 17 0.0012
244 VIITH NERVE PARALYSIS 4 0.0012
245 EJECTION FRACTION DECREASED 18 0.0012
246 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
247 ACTINIC KERATOSIS 3 0.0012
248 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0011
249 PETECHIAE 12 0.0011
250 TORSADE DE POINTES 9 0.0011
251 EXTRASYSTOLES 8 0.0011
252 COLD SWEAT 20 0.0011
253 OSTEOPENIA 17 0.0011
254 CONVULSION 64 0.0011
255 BRUXISM 6 0.0011
256 GAMBLING DISORDER 3 0.0011
257 NORMAL NEWBORN 6 0.0011
258 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
259 NECK MASS 3 0.0011
260 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
261 COMMUNICATION DISORDER 4 0.0010
262 MYOPATHY 9 0.0010
263 FAECAL INCONTINENCE 5 0.0010
264 PERICARDIAL EFFUSION 24 0.0010
265 HYPERTHYROIDISM 15 0.0010
266 THROAT TIGHTNESS 28 0.0010
267 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
268 PAIN IN JAW 29 0.0010
269 PREMATURE DELIVERY 16 0.0010
270 PERIPHERAL ISCHAEMIA 4 0.0010
271 DRUG ADMINISTRATION ERROR 30 0.0010
272 ARRHYTHMIA 46 0.0010
273 SPINAL STENOSIS 4 0.0010
274 COMA 46 0.0010
275 ACUTE CORONARY SYNDROME 8 0.0010
276 SCAB 11 0.0010
277 NEPHROPATHY 9 0.0010
278 MICTURITION URGENCY 11 0.0010
279 PARTIAL SEIZURES 5 0.0010
280 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 51 0.0009
281 HEPATIC LESION 4 0.0009
282 CARDIAC MURMUR 8 0.0009
283 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
284 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
285 IMMOBILE 4 0.0009
286 DYSPNOEA 515 0.0009
287 NEAR DEATH EXPERIENCE 3 0.0009
288 HYPOXIA 32 0.0009
289 ANAPHYLACTIC REACTION 50 0.0009
290 LETHARGY 52 0.0009
291 CARDIAC FAILURE ACUTE 6 0.0009
292 PREMATURE BABY 27 0.0009
293 HYPOKINESIA 13 0.0009
294 WHEEZING 53 0.0009
295 POSTOPERATIVE WOUND INFECTION 6 0.0009
296 PRODUCT LABEL ISSUE 6 0.0009
297 ACUTE RESPIRATORY FAILURE 17 0.0009
298 TACHYPNOEA 12 0.0009
299 CHOLECYSTITIS ACUTE 5 0.0009
300 CORONARY ARTERY OCCLUSION 12 0.0009
301 CARDIAC VALVE DISEASE 5 0.0009
302 NEUROLOGICAL SYMPTOM 5 0.0009
303 VOMITING 410 0.0009
304 RESPIRATION ABNORMAL 6 0.0009
305 DROOLING 6 0.0009
306 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
307 HYPERVENTILATION 5 0.0009
308 FEELING COLD 24 0.0009
309 AORTIC STENOSIS 3 0.0009
310 LIVER FUNCTION TEST ABNORMAL 25 0.0009
311 CORONARY ARTERY DISEASE 26 0.0009
312 HANGOVER 3 0.0009
313 SKIN TIGHTNESS 4 0.0008
314 FLUSHING 86 0.0008
315 CYANOSIS 13 0.0008
316 END STAGE RENAL DISEASE 15 0.0008
317 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
318 PARADOXICAL DRUG REACTION 3 0.0008
319 CARDIOMEGALY 10 0.0008
320 CARDIOMYOPATHY 12 0.0008
321 ELECTROCARDIOGRAM QT PROLONGED 29 0.0008
322 PRE-EXISTING CONDITION IMPROVED 5 0.0008
323 VEIN DISORDER 4 0.0008
324 BLOOD PRESSURE INCREASED 122 0.0008
325 SPINAL OSTEOARTHRITIS 7 0.0008
326 BLEPHAROSPASM 5 0.0008
327 BLOOD PRESSURE FLUCTUATION 19 0.0008
328 PETIT MAL EPILEPSY 4 0.0008
329 NAUSEA 618 0.0008
330 ANGINA UNSTABLE 5 0.0008
331 HYPERHIDROSIS 99 0.0008
332 EPIGASTRIC DISCOMFORT 3 0.0008
333 UNDERDOSE 56 0.0008
334 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
335 INCORRECT PRODUCT STORAGE 10 0.0008
336 INJECTION SITE DISCOMFORT 8 0.0008
337 AZOTAEMIA 3 0.0008
338 QUALITY OF LIFE DECREASED 10 0.0007
339 URINARY INCONTINENCE 22 0.0007
340 WRONG PRODUCT ADMINISTERED 5 0.0007
341 HIP SURGERY 4 0.0007
342 NO THERAPEUTIC RESPONSE 9 0.0007
343 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
344 ACUTE HEPATIC FAILURE 10 0.0007
345 HYPERURICAEMIA 3 0.0007
346 DIZZINESS 363 0.0007
347 ATELECTASIS 7 0.0007
348 PLEURAL EFFUSION 44 0.0007
349 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
350 REBOUND EFFECT 8 0.0007
351 SWOLLEN TONGUE 22 0.0007
352 ABSCESS LIMB 3 0.0007
353 EXERCISE TOLERANCE DECREASED 4 0.0007
354 OXYGEN SATURATION DECREASED 39 0.0007
355 PARAESTHESIA ORAL 10 0.0007
356 PANIC REACTION 5 0.0007
357 TREATMENT FAILURE 57 0.0007
358 METABOLIC ACIDOSIS 22 0.0007
359 CAESAREAN SECTION 8 0.0007
360 DIVERTICULUM INTESTINAL 3 0.0007
361 ONYCHOMYCOSIS 3 0.0007
362 HAEMORRHAGIC ANAEMIA 3 0.0007
363 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
364 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
365 MUSCLE TIGHTNESS 11 0.0007
366 MEDICAL DEVICE COMPLICATION 5 0.0007
367 FEELING DRUNK 5 0.0007
368 PULMONARY OEDEMA 30 0.0007
369 MACULAR DEGENERATION 8 0.0007
370 EAR DISORDER 3 0.0007
371 HEADACHE 410 0.0007
372 BLOOD PRESSURE ABNORMAL 13 0.0007
373 BOWEL MOVEMENT IRREGULARITY 5 0.0007
374 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
375 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
376 MUSCLE TWITCHING 15 0.0007
377 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
378 SCOLIOSIS 4 0.0006
379 BASAL CELL CARCINOMA 10 0.0006
380 ARTERIOSCLEROSIS 6 0.0006
381 SQUAMOUS CELL CARCINOMA 6 0.0006
382 FEAR 17 0.0006
383 LOW BIRTH WEIGHT BABY 5 0.0006
384 SLEEP APNOEA SYNDROME 12 0.0006
385 LIMB DISCOMFORT 19 0.0006
386 HYPERTENSION 130 0.0006
387 RENAL FAILURE ACUTE 26 0.0006
388 DRUG INTERACTION 97 0.0006
389 HYPOGAMMAGLOBULINAEMIA 4 0.0006
390 BREATH SOUNDS ABNORMAL 3 0.0006
391 ABDOMINAL DISCOMFORT 102 0.0006
392 HYPERVOLAEMIA 3 0.0006
393 FOOT OPERATION 3 0.0006
394 SKIN CANCER 13 0.0006
395 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
396 ANEURYSM 3 0.0006
397 HEMIPLEGIA 5 0.0006
398 BREAST MASS 4 0.0006
399 HAEMODIALYSIS 5 0.0006
400 SENSATION OF FOREIGN BODY 5 0.0006
401 COLITIS ISCHAEMIC 4 0.0006
402 CHRONIC KIDNEY DISEASE 45 0.0006
403 CORONARY ARTERIAL STENT INSERTION 3 0.0006
404 PAIN IN EXTREMITY 174 0.0006
405 STEVENS-JOHNSON SYNDROME 13 0.0006
406 DYSARTHRIA 22 0.0006
407 PERIPHERAL VASCULAR DISORDER 3 0.0006
408 MUSCULOSKELETAL DISCOMFORT 10 0.0006
409 JOINT EFFUSION 4 0.0006
410 FEELING JITTERY 11 0.0006
411 INFUSION RELATED REACTION 38 0.0006
412 MUSCULOSKELETAL PAIN 30 0.0006
413 SPEECH DISORDER 30 0.0006
414 CATATONIA 3 0.0006
415 DEFAECATION URGENCY 4 0.0006
416 IMMUNOSUPPRESSION 5 0.0006
417 CHOKING 11 0.0006
418 FACIAL PAIN 5 0.0006
419 THERAPY NON-RESPONDER 25 0.0006
420 OESOPHAGITIS 6 0.0005
421 NONSPECIFIC REACTION 3 0.0005
422 ROTATOR CUFF SYNDROME 7 0.0005
423 INTESTINAL ISCHAEMIA 3 0.0005
424 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
425 COAGULOPATHY 9 0.0005
426 MUSCLE SPASMS 99 0.0005
427 RASH MACULO-PAPULAR 12 0.0005
428 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
429 OSTEOPOROSIS 22 0.0005
430 BLISTER 30 0.0005
431 ORAL CANDIDIASIS 7 0.0005
432 HEART RATE IRREGULAR 12 0.0005
433 PULMONARY CONGESTION 7 0.0005
434 DISORIENTATION 21 0.0005
435 IMPAIRED DRIVING ABILITY 6 0.0005
436 GENERALISED ERYTHEMA 3 0.0005
437 ASPARTATE AMINOTRANSFERASE INCREASED 28 0.0005
438 CEREBROVASCULAR ACCIDENT 89 0.0005
439 ANGINA PECTORIS 15 0.0005
440 ACIDOSIS 4 0.0005
441 POST PROCEDURAL COMPLICATION 10 0.0005
442 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
443 BURNING SENSATION 36 0.0005
444 THERAPY PARTIAL RESPONDER 8 0.0005
445 HYPOVOLAEMIA 3 0.0005
446 PALPITATIONS 60 0.0005
447 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
448 PULMONARY HAEMORRHAGE 4 0.0005
449 MYOCARDIAL INFARCTION 89 0.0005
450 RENAL CYST 4 0.0005
451 NECK PAIN 28 0.0005
452 BLOOD DISORDER 4 0.0005
453 DEVICE OCCLUSION 7 0.0005
454 VAGINAL DISCHARGE 5 0.0005
455 PANIC ATTACK 18 0.0005
456 FOETAL GROWTH RESTRICTION 3 0.0005
457 PARALYSIS 7 0.0005
458 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
459 SPINAL OPERATION 6 0.0005
460 HYPERAESTHESIA 4 0.0005
461 BACK PAIN 113 0.0005
462 CHILLS 57 0.0005
463 SPINAL COMPRESSION FRACTURE 4 0.0005
464 HYPERBILIRUBINAEMIA 5 0.0005
465 TENDERNESS 5 0.0005
466 DYSSTASIA 14 0.0005
467 WEIGHT FLUCTUATION 5 0.0005
468 DISCOMFORT 29 0.0005
469 INFUSION SITE ERYTHEMA 4 0.0005
470 INJECTION SITE IRRITATION 6 0.0005
471 ABDOMINAL PAIN 109 0.0005
472 SEROTONIN SYNDROME 9 0.0005
473 ANURIA 4 0.0005
474 CARDIAC FLUTTER 3 0.0005
475 DECREASED ACTIVITY 5 0.0005
476 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
477 BLOOD CREATININE INCREASED 30 0.0005
478 LOCAL SWELLING 8 0.0005
479 BLOOD GLUCOSE FLUCTUATION 5 0.0005
480 BLOOD CALCIUM INCREASED 4 0.0005
481 TOOTH INFECTION 6 0.0005
482 GRIP STRENGTH DECREASED 4 0.0005
483 MYALGIA 77 0.0005
484 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
485 HYPERSENSITIVITY 84 0.0005
486 ACUTE KIDNEY INJURY 69 0.0005
487 RESPIRATORY RATE INCREASED 4 0.0005
488 HYPERTENSIVE CRISIS 5 0.0004
489 HAIR TEXTURE ABNORMAL 6 0.0004
490 HYPOAESTHESIA 67 0.0004
491 SKIN INFECTION 5 0.0004
492 PRODUCT ADMINISTRATION ERROR 9 0.0004
493 BRONCHIECTASIS 3 0.0004
494 RASH PRURITIC 24 0.0004
495 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
496 TOOTHACHE 8 0.0004
497 DISEASE RECURRENCE 21 0.0004
498 INJURY 31 0.0004
499 RESTLESS LEGS SYNDROME 8 0.0004
500 EXOSTOSIS 4 0.0004
501 RIB FRACTURE 9 0.0004
502 LYMPHOEDEMA 3 0.0004
503 NERVE COMPRESSION 4 0.0004
504 LARGE INTESTINE POLYP 3 0.0004
505 FEELING ABNORMAL 103 0.0004
506 MULTIPLE FRACTURES 7 0.0004
507 BLOOD SODIUM DECREASED 8 0.0004
508 HAND FRACTURE 3 0.0004
509 PRODUCT PACKAGING ISSUE 4 0.0004
510 PARAESTHESIA 66 0.0004
511 EYE INFLAMMATION 4 0.0004
512 DEVICE BREAKAGE 17 0.0004
513 EXPOSURE DURING PREGNANCY 26 0.0004
514 ANXIETY 119 0.0004
515 MUSCLE RIGIDITY 5 0.0004
516 GASTRITIS 11 0.0004
517 URTICARIA 70 0.0004
518 IMPAIRED QUALITY OF LIFE 6 0.0004
519 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
520 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
521 RENAL FAILURE 55 0.0004
522 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
523 CRYING 15 0.0004
524 APATHY 6 0.0004
525 MIGRAINE 39 0.0004
526 FEELING HOT 25 0.0004
527 RENAL TUBULAR NECROSIS 4 0.0004
528 KNEE OPERATION 4 0.0004
529 MULTI-ORGAN FAILURE 7 0.0004
530 MOVEMENT DISORDER 13 0.0004
531 RENAL INJURY 12 0.0004
532 EYE SWELLING 15 0.0004
533 LACTIC ACIDOSIS 13 0.0004
534 SNEEZING 9 0.0004
535 SALIVARY HYPERSECRETION 4 0.0004
536 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
537 HYPERKALAEMIA 14 0.0004
538 HYPOAESTHESIA ORAL 6 0.0004
539 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
540 HEAD DISCOMFORT 7 0.0004
541 DEVICE FAILURE 6 0.0004
542 EYELID PTOSIS 4 0.0004
543 BODY TEMPERATURE INCREASED 8 0.0004
544 DEVICE LEAKAGE 17 0.0004
545 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
546 MYDRIASIS 5 0.0004
547 DRUG RESISTANCE 10 0.0004
548 GAIT INABILITY 13 0.0004
549 TENDONITIS 6 0.0004
550 SKIN ULCER 10 0.0004
551 HYPOALBUMINAEMIA 3 0.0004
552 RESPIRATORY FAILURE 28 0.0004
553 HYPERSOMNIA 11 0.0004
554 GASTROINTESTINAL INFLAMMATION 3 0.0004
555 BRAIN FOG 6 0.0004
556 DERMATITIS 8 0.0004
557 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
558 BLOOD GLUCOSE ABNORMAL 7 0.0004
559 ABDOMINAL PAIN UPPER 78 0.0004
560 PULMONARY EMBOLISM 36 0.0004
561 NASAL DISCOMFORT 3 0.0004
562 CELLULITIS 19 0.0004
563 DIARRHOEA 242 0.0004
564 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
565 BODY HEIGHT DECREASED 4 0.0004
566 SENSORY DISTURBANCE 6 0.0004
567 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
568 PHOTOPHOBIA 7 0.0004
569 FIBROMYALGIA 9 0.0004
570 SINUS CONGESTION 5 0.0004
571 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
572 FOOT FRACTURE 7 0.0004
573 DYSKINESIA 15 0.0004
574 SWELLING FACE 24 0.0004
575 GASTRIC ULCER 7 0.0004
576 DECUBITUS ULCER 3 0.0004
577 SKIN LACERATION 4 0.0004
578 PRODUCT PRESCRIBING ISSUE 8 0.0004
579 MUSCULOSKELETAL STIFFNESS 32 0.0004
580 PULMONARY FIBROSIS 7 0.0004
581 PERIPHERAL COLDNESS 5 0.0004
582 HAIR DISORDER 3 0.0004
583 SOMNOLENCE 73 0.0004
584 MALAISE 159 0.0004
585 ASTHENIA 136 0.0004
586 ANGIOEDEMA 16 0.0004
587 DENTAL CARIES 4 0.0004
588 LIP SWELLING 12 0.0004
589 EAR PAIN 7 0.0004
590 INJECTION SITE PAIN 110 0.0004
591 APHONIA 5 0.0004
592 ATRIAL SEPTAL DEFECT 3 0.0004
593 ORAL PAIN 8 0.0004
594 OCULAR DISCOMFORT 4 0.0004
595 EMOTIONAL DISTRESS 43 0.0004
596 EYE PAIN 20 0.0004
597 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
598 ANAPHYLACTIC SHOCK 9 0.0003
599 SKIN DISCOLOURATION 16 0.0003
600 DRUG INEFFECTIVE 457 0.0003
601 HYPOKALAEMIA 16 0.0003
602 TASTE DISORDER 7 0.0003
603 GROIN PAIN 3 0.0003
604 NIGHT SWEATS 11 0.0003
605 BACTERAEMIA 4 0.0003
606 MYOCLONUS 4 0.0003
607 GOUT 6 0.0003
608 THROAT IRRITATION 15 0.0003
609 LEUKOCYTOSIS 6 0.0003
610 PELVIC PAIN 6 0.0003
611 SKIN LESION 9 0.0003
612 TINNITUS 15 0.0003
613 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
614 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
615 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
616 NO ADVERSE EVENT 59 0.0003
617 OFF LABEL USE 284 0.0003
618 CARDIAC FAILURE 26 0.0003
619 MEDICATION ERROR 18 0.0003
620 LYMPHOMA 5 0.0003
621 MUSCULOSKELETAL CHEST PAIN 5 0.0003
622 HEPATIC STEATOSIS 6 0.0003
623 DELUSION 5 0.0003
624 ILEUS 4 0.0003
625 AGEUSIA 8 0.0003
626 SWELLING 30 0.0003
627 DERMATITIS ALLERGIC 4 0.0003
628 COLITIS 12 0.0003
629 ERYTHEMA 65 0.0003
630 BLOOD URINE PRESENT 6 0.0003
631 OBESITY 5 0.0003
632 AGITATION 23 0.0003
633 CARDIAC FAILURE CONGESTIVE 25 0.0003
634 HYPERCHOLESTEROLAEMIA 3 0.0003
635 CARDIAC DISORDER 29 0.0003
636 RASH GENERALISED 8 0.0003
637 HAEMATOMA 8 0.0003
638 NODULE 4 0.0003
639 NERVOUSNESS 16 0.0003
640 HEPATOMEGALY 3 0.0003
641 NEPHROLITHIASIS 14 0.0003
642 BEDRIDDEN 4 0.0003
643 UNEVALUABLE EVENT 23 0.0003
644 STAPHYLOCOCCAL INFECTION 10 0.0003
645 VISION BLURRED 41 0.0003
646 OEDEMA PERIPHERAL 36 0.0003
647 MOTOR DYSFUNCTION 3 0.0003
648 AMNESIA 19 0.0003
649 BLOOD GLUCOSE DECREASED 14 0.0003
650 HYPOMAGNESAEMIA 4 0.0003
651 BONE DENSITY DECREASED 9 0.0003
652 HAEMOPTYSIS 8 0.0003
653 RASH MACULAR 10 0.0003
654 ENCEPHALOPATHY 7 0.0003
655 CONFUSIONAL STATE 46 0.0003
656 DYSPHAGIA 27 0.0003
657 HEAD INJURY 9 0.0003
658 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
659 OSTEOARTHRITIS 12 0.0003
660 CONDITION AGGRAVATED 86 0.0003
661 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
662 SEPSIS 31 0.0003
663 GASTROENTERITIS VIRAL 5 0.0003
664 BIPOLAR DISORDER 3 0.0003
665 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
666 HYPERGLYCAEMIA 10 0.0003
667 IMPAIRED HEALING 9 0.0003
668 INJECTION SITE SWELLING 21 0.0003
669 OCULAR HYPERAEMIA 13 0.0003
670 HAEMOGLOBIN DECREASED 28 0.0003
671 GASTROINTESTINAL PAIN 3 0.0003
672 PRODUCT QUALITY ISSUE 37 0.0003
673 PAIN 167 0.0003
674 FOOT DEFORMITY 3 0.0003
675 SKIN HAEMORRHAGE 4 0.0003
676 TRANSAMINASES INCREASED 6 0.0003
677 PULMONARY MASS 4 0.0003
678 EYE PRURITUS 9 0.0003
679 ECZEMA 14 0.0003
680 RESPIRATORY DISORDER 8 0.0003
681 ANAEMIA 51 0.0003
682 HYPONATRAEMIA 15 0.0003
683 DYSPNOEA EXERTIONAL 10 0.0003
684 DYSPEPSIA 26 0.0003
685 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
686 MUSCULAR WEAKNESS 30 0.0003
687 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
688 CHOLECYSTECTOMY 3 0.0003
689 MYOCARDITIS 3 0.0003
690 NEOPLASM 3 0.0003
691 ADVERSE EVENT 24 0.0003
692 EMOTIONAL DISORDER 8 0.0003
693 FREQUENT BOWEL MOVEMENTS 7 0.0003
694 MADAROSIS 3 0.0003
695 ANKLE FRACTURE 4 0.0003
696 HAEMORRHAGE 27 0.0003
697 ELECTROLYTE IMBALANCE 3 0.0003
698 PNEUMONITIS 7 0.0003
699 ASTHMA 29 0.0003
700 RECTAL HAEMORRHAGE 11 0.0003
701 GAIT DISTURBANCE 49 0.0003
702 COVID-19 PNEUMONIA 3 0.0003
703 PERIPHERAL SWELLING 39 0.0003
704 ATAXIA 3 0.0003
705 SINUS DISORDER 5 0.0003
706 HAEMATOCRIT DECREASED 5 0.0003
707 HALLUCINATION, AUDITORY 4 0.0003
708 ULCER 4 0.0003
709 ACCIDENT 3 0.0003
710 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
711 SCIATICA 4 0.0003
712 HYPOTHYROIDISM 8 0.0003
713 RASH 109 0.0002
714 RENAL IMPAIRMENT 21 0.0002
715 SPINAL FRACTURE 5 0.0002
716 FATIGUE 193 0.0002
717 HYPOGLYCAEMIA 12 0.0002
718 NOCTURIA 3 0.0002
719 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
720 FEEDING DISORDER 5 0.0002
721 ACCIDENTAL OVERDOSE 9 0.0002
722 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
723 RED BLOOD CELL COUNT DECREASED 7 0.0002
724 EYE DISORDER 8 0.0002
725 MANIA 4 0.0002
726 ABASIA 6 0.0002
727 GENERALISED OEDEMA 3 0.0002
728 DYSGEUSIA 18 0.0002
729 PHOTOSENSITIVITY REACTION 4 0.0002
730 INFECTION 35 0.0002
731 DRUG LEVEL INCREASED 4 0.0002
732 HAIR COLOUR CHANGES 3 0.0002
733 INJECTION SITE DISCOLOURATION 3 0.0002
734 FUNGAL INFECTION 8 0.0002
735 PEMPHIGUS 3 0.0002
736 POLLAKIURIA 10 0.0002
737 URINARY RETENTION 8 0.0002
738 BRAIN OEDEMA 3 0.0002
739 DEPRESSION 54 0.0002
740 MOBILITY DECREASED 17 0.0002
741 EATING DISORDER 5 0.0002
742 HYPOPHAGIA 6 0.0002
743 GASTROINTESTINAL DISORDER 21 0.0002
744 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
745 BLOOD POTASSIUM DECREASED 7 0.0002
746 LACRIMATION INCREASED 7 0.0002
747 PRODUCTIVE COUGH 11 0.0002
748 ORTHOSTATIC HYPOTENSION 4 0.0002
749 EOSINOPHILIA 4 0.0002
750 COVID-19 40 0.0002
751 IMMUNE SYSTEM DISORDER 3 0.0002
752 PRURITUS 87 0.0002
753 HOT FLUSH 17 0.0002
754 EYE HAEMORRHAGE 3 0.0002
755 NERVOUS SYSTEM DISORDER 7 0.0002
756 ISCHAEMIC STROKE 4 0.0002
757 JOINT RANGE OF MOTION DECREASED 3 0.0002
758 JOINT SWELLING 27 0.0002
759 CEREBRAL HAEMORRHAGE 8 0.0002
760 DYSPHONIA 13 0.0002
761 IMPAIRED GASTRIC EMPTYING 3 0.0002
762 GINGIVAL BLEEDING 3 0.0002
763 RESTLESSNESS 8 0.0002
764 HAEMATOCHEZIA 12 0.0002
765 SHOCK 5 0.0002
766 OROPHARYNGEAL PAIN 20 0.0002
767 ORAL DISCOMFORT 3 0.0002
768 RHABDOMYOLYSIS 9 0.0002
769 HUNGER 3 0.0002
770 COORDINATION ABNORMAL 3 0.0002
771 STOMATITIS 13 0.0002
772 MIDDLE INSOMNIA 4 0.0002
773 CHOLELITHIASIS 7 0.0002
774 DIALYSIS 3 0.0002
775 HYPOCALCAEMIA 4 0.0002
776 DRY MOUTH 17 0.0002
777 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
778 CHOLESTASIS 4 0.0002
779 ANOSMIA 3 0.0002
780 PNEUMONIA 67 0.0002
781 ERUCTATION 4 0.0002
782 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
783 HAEMORRHOIDS 4 0.0002
784 SURGERY 12 0.0002
785 SKIN FISSURES 4 0.0002
786 HAEMATURIA 7 0.0002
787 DISTURBANCE IN ATTENTION 11 0.0002
788 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
789 LABORATORY TEST ABNORMAL 6 0.0002
790 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
791 VISUAL IMPAIRMENT 25 0.0002
792 DELIRIUM 7 0.0002
793 RHINORRHOEA 13 0.0002
794 UPPER LIMB FRACTURE 4 0.0002
795 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
796 COUGH 56 0.0002
797 ARTHRALGIA 83 0.0002
798 BONE LOSS 3 0.0002
799 FULL BLOOD COUNT DECREASED 4 0.0002
800 LYMPHADENOPATHY 7 0.0002
801 ABDOMINAL PAIN LOWER 5 0.0002
802 CARDIOVASCULAR DISORDER 5 0.0002
803 VERTIGO 12 0.0002
804 SKIN IRRITATION 9 0.0002
805 FEBRILE NEUTROPENIA 13 0.0002
806 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
807 DEVICE RELATED INFECTION 3 0.0002
808 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
809 PRODUCT PREPARATION ERROR 4 0.0002
810 LUNG INFECTION 3 0.0002
811 EXPOSURE VIA SKIN CONTACT 5 0.0002
812 TOOTH LOSS 4 0.0002
813 PULMONARY HYPERTENSION 4 0.0002
814 ABDOMINAL DISTENSION 20 0.0002
815 DEAFNESS 5 0.0002
816 JOINT STIFFNESS 5 0.0002
817 HALLUCINATION, VISUAL 4 0.0002
818 ADVERSE DRUG REACTION 17 0.0002
819 ABSCESS 3 0.0002
820 BONE PAIN 11 0.0002
821 THROMBOCYTOPENIA 21 0.0002
822 URINARY TRACT INFECTION 32 0.0002
823 IMPAIRED WORK ABILITY 4 0.0002
824 IRRITABLE BOWEL SYNDROME 4 0.0002
825 LIVER FUNCTION TEST INCREASED 4 0.0002
826 HYPOACUSIS 8 0.0002
827 DEEP VEIN THROMBOSIS 12 0.0002
828 BACK DISORDER 3 0.0002
829 OEDEMA 10 0.0002
830 SLEEP DISORDER 13 0.0002
831 INCORRECT DOSE ADMINISTERED 42 0.0002
832 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
833 METASTASES TO BONE 3 0.0002
834 CYTOMEGALOVIRUS INFECTION 3 0.0002
835 PROCEDURAL PAIN 5 0.0002
836 ARTHROPATHY 10 0.0002
837 SKIN DISORDER 6 0.0002
838 DRY SKIN 24 0.0002
839 COLITIS ULCERATIVE 8 0.0002
840 DEVICE ISSUE 16 0.0002
841 ARTHRITIS 14 0.0002
842 PANCREATITIS ACUTE 4 0.0002
843 FACE OEDEMA 3 0.0002
844 SKIN EXFOLIATION 15 0.0002
845 HEPATIC ENZYME INCREASED 12 0.0002
846 BRONCHITIS 13 0.0002
847 PRODUCT USE ISSUE 33 0.0002
848 INTENTIONAL DOSE OMISSION 5 0.0002
849 MEMORY IMPAIRMENT 24 0.0002
850 PRODUCT SUBSTITUTION ISSUE 10 0.0002
851 DEVICE DEFECTIVE 3 0.0002
852 TOXICITY TO VARIOUS AGENTS 29 0.0002
853 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
854 DERMATITIS ATOPIC 9 0.0002
855 LYMPHOCYTE COUNT DECREASED 3 0.0002
856 CONSTIPATION 37 0.0002
857 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
858 GALLBLADDER DISORDER 3 0.0002
859 PRODUCT PRESCRIBING ERROR 4 0.0002
860 CONTUSION 16 0.0002
861 NEURALGIA 4 0.0002
862 SEPTIC SHOCK 7 0.0002
863 HEPATIC FUNCTION ABNORMAL 6 0.0002
864 EPISTAXIS 12 0.0002
865 HEPATIC CIRRHOSIS 3 0.0002
866 HALLUCINATION 12 0.0002
867 FLATULENCE 9 0.0002
868 FRACTURE 3 0.0002
869 ACNE 12 0.0002
870 MUSCULOSKELETAL DISORDER 3 0.0002
871 HERPES ZOSTER 9 0.0002
872 PYREXIA 54 0.0002
873 ERECTILE DYSFUNCTION 4 0.0002
874 HERNIA 3 0.0002
875 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
876 WEIGHT DECREASED 43 0.0002
877 DIPLOPIA 4 0.0002
878 ORAL HERPES 3 0.0002
879 RESPIRATORY TRACT INFECTION 4 0.0002
880 KIDNEY INFECTION 3 0.0002
881 OSTEONECROSIS 5 0.0002
882 DISABILITY 3 0.0002
883 DEPRESSED MOOD 8 0.0002
884 CATARACT 9 0.0002
885 EAR INFECTION 4 0.0002
886 VIRAL INFECTION 5 0.0002
887 RENAL DISORDER 7 0.0002
888 BLOOD CHOLESTEROL INCREASED 7 0.0002
889 DEHYDRATION 20 0.0001
890 CYTOKINE RELEASE SYNDROME 3 0.0001
891 MENSTRUATION IRREGULAR 4 0.0001
892 JAUNDICE 4 0.0001
893 THERAPEUTIC RESPONSE DECREASED 9 0.0001
894 BLOOD BILIRUBIN INCREASED 4 0.0001
895 LIMB INJURY 4 0.0001
896 INSOMNIA 39 0.0001
897 DECREASED APPETITE 34 0.0001
898 TREATMENT NONCOMPLIANCE 8 0.0001
899 ILLNESS 15 0.0001
900 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
901 DIVERTICULITIS 4 0.0001
902 FALL 48 0.0001
903 BLOOD GLUCOSE INCREASED 27 0.0001
904 DEMENTIA 4 0.0001
905 LUNG DISORDER 7 0.0001
906 JOINT INJURY 3 0.0001
907 AGGRESSION 7 0.0001
908 EYE IRRITATION 8 0.0001
909 BALANCE DISORDER 12 0.0001
910 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
911 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
912 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
913 VAGINAL HAEMORRHAGE 6 0.0001
914 MENTAL DISORDER 6 0.0001
915 SINUSITIS 14 0.0001
916 NASAL CONGESTION 8 0.0001
917 DYSURIA 5 0.0001
918 INFLAMMATION 7 0.0001
919 GLOSSODYNIA 3 0.0001
920 HEPATIC FAILURE 4 0.0001
921 INTESTINAL OBSTRUCTION 5 0.0001
922 PLATELET COUNT DECREASED 14 0.0001
923 SUICIDAL IDEATION 12 0.0001
924 INJECTION SITE ERYTHEMA 16 0.0001
925 DRUG-INDUCED LIVER INJURY 4 0.0001
926 INFLUENZA 14 0.0001
927 HIP FRACTURE 4 0.0001
928 THROMBOSIS 10 0.0001
929 LOCALISED INFECTION 3 0.0001
930 MENTAL IMPAIRMENT 3 0.0001
931 BLINDNESS 5 0.0001
932 LUNG NEOPLASM MALIGNANT 5 0.0001
933 NASOPHARYNGITIS 22 0.0001
934 WITHDRAWAL SYNDROME 5 0.0001
935 HAEMATEMESIS 3 0.0001
936 DISEASE PROGRESSION 14 0.0001
937 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
938 DEATH 100 0.0001
939 OVERDOSE 25 0.0001
940 DEVICE MALFUNCTION 8 0.0001
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
942 THERAPY INTERRUPTED 8 0.0001
943 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
944 PAIN OF SKIN 3 0.0001
945 HOSPITALISATION 17 0.0001
946 MOOD ALTERED 3 0.0001
947 PRODUCT DOSE OMISSION ISSUE 32 0.0001
948 ABNORMAL DREAMS 3 0.0001
949 INJECTION SITE MASS 4 0.0001
950 PSORIASIS 14 0.0001
951 WEIGHT INCREASED 24 0.0001
952 COGNITIVE DISORDER 5 0.0001
953 NEUROPATHY PERIPHERAL 10 0.0001
954 NEOPLASM MALIGNANT 7 0.0001
955 RASH ERYTHEMATOUS 5 0.0001
956 NEUTROPENIA 14 0.0001
957 ABNORMAL BEHAVIOUR 4 0.0001
958 INJECTION SITE BRUISING 8 0.0001
959 DRY EYE 5 0.0001
960 INJECTION SITE HAEMORRHAGE 8 0.0001
961 IRRITABILITY 6 0.0001
962 EXTRA DOSE ADMINISTERED 4 0.0001
963 FLUID RETENTION 5 0.0001
964 NEUTROPHIL COUNT DECREASED 4 0.0001
965 THERAPY CESSATION 5 0.0001
966 EXPIRED PRODUCT ADMINISTERED 3 0.0001
967 LIVER DISORDER 4 0.0001
968 ANGER 3 0.0001
969 GASTRIC DISORDER 3 0.0001
970 ALOPECIA 17 0.0001
971 DRUG INTOLERANCE 8 0.0001
972 SUICIDE ATTEMPT 5 0.0001
973 C-REACTIVE PROTEIN INCREASED 3 0.0001
974 ILL-DEFINED DISORDER 5 0.0001
975 PRODUCT STORAGE ERROR 7 0.0001
976 INTENTIONAL PRODUCT MISUSE 7 0.0001
977 DIABETES MELLITUS 6 0.0001
978 PANCREATITIS 4 0.0001
979 INJECTION SITE REACTION 5 0.0001
980 SKIN BURNING SENSATION 5 0.0001
981 DEVICE DISLOCATION 3 0.0001
982 DRUG WITHDRAWAL SYNDROME 6 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
984 PRODUCT DOSE OMISSION 4 0.0001
985 INFLUENZA LIKE ILLNESS 5 0.0001
986 LEUKOPENIA 3 0.0001
987 INJECTION SITE PRURITUS 4 0.0001
988 DRUG DEPENDENCE 8 0.0000
989 RHEUMATOID ARTHRITIS 5 0.0000
990 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
991 BREAST CANCER 4 0.0000
992 DRUG ABUSE 3 0.0000
993 DRUG DOSE OMISSION 3 0.0000